Prophylaxis of vasovagal reaction with Atrohist Plus.
Koop
M R
MR
Becker
N
N
D000284:Administration, Oral; D000328:Adult; D001285:Atropine / Q000627:therapeutic use*; D002744:Chlorpheniramine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D008297:Male; D009883:Ophthalmic Solutions / Q000008:administration & dosage; D010656:Phenylephrine / Q000627:therapeutic use*; D010665:Phenylpropanolamine / Q000627:therapeutic use*; D012601:Scopolamine / Q000627:therapeutic use*; D019462:Syncope, Vasovagal / Q000209:etiology / Q000517:prevention & control*; D013607:Tablets; D014065:Tonometry, Ocular / Q000009:adverse effects*; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D009883:Ophthalmic Solutions; D013607:Tablets; D014662:Vasoconstrictor Agents; D010656:Phenylephrine; D010665:Phenylpropanolamine; D002744:Chlorpheniramine; D001285:Atropine; D012601:Scopolamine